https://www.prnewswire.com/news-releases/atox-bio-announces-exercise-by-barda-of-next-option-period-to-support-continued-development-of-reltecimod-for-nsti-300870195.html
/PRNewswire/ -- Atox Bio, a late stage clinical company developing immunotherapies for critically ill patients, today announced the Biomedical Advanced...
atoxbioannouncesexercisebarda
https://atoxgrupo.com/
Jan 22, 2026 - Potencia tu negocio con sistemas de almacenaje y estanterías metálicas. Soluciones eficientes para tu negocio. Contáctanos: +34 985 310 111
sistemas de almacenajeatoxgrupo